Evidence map›Paper›PMID 17697196›Full record

ReviewClinical and experimental immunology2007

Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

C Bacchelli, S Buckridge, A J Thrasher, H B Gaspar

Open access · greenAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. B Cell Disorders in Children-Part I.Current allergy and asthma reports · 2020
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rare variants at 16p11.2 are associated with common variable immunodeficiency.The Journal of allergy and clinical immunology · 2015
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Immune globulin subcutaneous (human), 20% liquid.P & T : a peer-reviewed journal for formulary management · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

C BacchelliMolecular Immunology Unit, Institute of Child Health, London, UK.
S Buckridge
A J Thrasher
H B Gaspar
Great Ormond Street Hospital · GBUniversity College London · GB

Funding

Medical Research Council G0501468
6 · The paper itself

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency that typically affects adults and is characterized by abnormalities of quantative and qualitative humoral function that are heterogeneous in their immunological profile and clinical manifestations. The recent identification of four monogenic defects that result in the CVID phenotype also demonstrates that the genetic basis of CVID is highly variable. Mutations in the genes encoding the tumour necrosis factor (TNF) superfamily receptors transmembrane activator and calcium-modulating ligand interactor (TACI) and B cell activation factor of the TNF family receptor (BAFF-R), CD19 and the co-stimulatory molecule inducible co-stimulator molecule (ICOS) all lead to CVID and illustrate the complex interplay required to co-ordinate an effective humoral immune response. The molecular mechanisms leading to the immune defect are still not understood clearly and particularly in the case of TACI, where a number of heterozygous mutations have been found in affected individuals, the molecular pathogenesis of disease requires further elucidation. Together these defects account for perhaps 10-15% of all cases of CVID and it is highly likely that further genetic defects will be identified.

Indexed as

Antigens, CD19Antigens, Differentiation, T-LymphocyteCommon Variable ImmunodeficiencyGenetic Predisposition to DiseaseHumansInducible T-Cell Co-Stimulator ProteinTransmembrane Activator and CAML Interactor ProteinAntigens, CD19Antigens, Differentiation, T-LymphocyteICOS protein, humanInducible T-Cell Co-Stimulator ProteinTNFRSF13B protein, humanTransmembrane Activator and CAML Interactor Protein

Identifiers

PMID17697196
PMCPMC2219326
OpenAlexW2159435028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.